Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:adalimumab
|
| gptkbp:approvalYear |
2019-07-23
|
| gptkbp:ATCCode |
L04AB04
|
| gptkbp:biosimilar |
gptkb:Humira
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hadlima
|
| gptkbp:indication |
gptkb:Crohn's_disease
gptkb:psoriatic_arthritis ulcerative colitis rheumatoid arthritis ankylosing spondylitis plaque psoriasis |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Samsung_Bioepis
|
| gptkbp:marketedAs |
gptkb:Organon
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:bfsParent |
gptkb:Samsung_Bioepis
gptkb:adalimumab |
| gptkbp:bfsLayer |
7
|